Back to WOCKPHARMA
Clear

Board Meetings for WOCKPHARMA

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
WOCKPHARMAWockhardt Limited11 May 2020Financial Results/Fund RaisingTo consider and approve the financial results for the period ended March 31, 2020 and Fund Raising
PDF
WOCKPHARMAWockhardt Limited27 Jan 2020Financial ResultsTo consider and approve the financial results for the period ended December 31, 2019
PDF
WOCKPHARMAWockhardt Limited07 Nov 2019Financial ResultsTo consider and approve the financial results for the period ended September 30, 2019
PDF
WOCKPHARMAWockhardt Limited14 Aug 2019Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2019
PDF
WOCKPHARMAWockhardt Limited06 May 2019Financial Results/Dividend/Fund RaisingTo consider and approve the financial results for the period ended March 31, 2019, dividend on Preference Shares and Fund Raising
PDF
WOCKPHARMAWockhardt Limited28 Jan 2019Financial ResultsTo consider and approve the financial results for the period ended December 31, 2018
PDF
WOCKPHARMAWockhardt Limited10 Nov 2018Financial ResultsTo consider and approve the Unaudited financial results for the quarter ended September 30, 2018
PDF
WOCKPHARMAWockhardt Limited04 Aug 2018Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2018
PDF
WOCKPHARMAWockhardt Limited04 May 2018Financial ResultsTo consider and approve the financial results for the period ended March 31, 2018
PDF
WOCKPHARMAWockhardt Limited04 May 2018Fund RaisingTo consider Fund Raising
PDF
WOCKPHARMAWockhardt Limited29 Jan 2018ResultsInter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2017.
PDF
WOCKPHARMAWockhardt Limited30 Oct 2017Resultsinter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2017.
PDF
WOCKPHARMAWockhardt Limited02 Aug 2017ResultsInter-alia, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2017.
PDF
WOCKPHARMAWockhardt Limited04 May 2017Results/Dividendinter-alia, to consider and: (i) approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2017; (ii) recommend dividend on Preference Shares; (iii) approve raising of funds through issuance of Non-Convertible Debentures on private placement basis; and (iv) approve raising of funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and / or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/or private offerings, Qualified Institutions Placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to such approvals as may be required, and to approve ancillary actions for the above mentioned fund raising. Further, please note that pursuant to Company s code of conduct for regulating, monitoring, reporting trading by designated persons, the Trading window for dealing in the shares of the Company will be closed from April 22, 2017 to May 06, 2017 (both days inclusive). The Trading Window shall re-open with effect from May 07, 2017.
PDF
WOCKPHARMAWockhardt Limited24 Jan 2017Resultsinter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2016.
PDF
Showing page 4 of 8 (115 total items)
PreviousNext